Antiplatelet agents reduce risk of postoperative IOL bleeding

Article

The use of antiplatelet agents, such as aspirin and clopidogrel, are safer to use compared to anticoagulation (warfarin) therapy, according to the American Journal of Ophthalmology.

The use of antiplatelet agents, such as aspirin and clopidogrel, are safer to use compared to anticoagulation (warfarin) therapy, according to the American Journal of Ophthalmology.

Dr Jaeryung Oh et al., Department of Ophthalmology, Anam Hospital, Korea University College of Medicine, Seoul, Korea, conducted an observational, retrospective case control study on 822 patients who underwent vitreoretinal surgery in 1994, 2004 and 2008.

The outcome measures included the proportion using antiplatelets or anticoagulants, the occurrence of early postoperative intraocular bleeding in patients, and clinical outcomes of the haemorrhage.

The findings demonstrated that the rate of anticoagulant therapy didn't vary and lowers the risk of intraocular haemorrhage after vitrectomy.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.